These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7391338)

  • 1. [Modalities and classes of modalities of action of physiologically active substances of the receptor type during screening].
    Dmitrieva NV; Kaplun AB; Kosolapov SS; Lobanov VI; Nizhniĭ SV
    Izv Akad Nauk SSSR Biol; 1980; (3):408-14. PubMed ID: 7391338
    [No Abstract]   [Full Text] [Related]  

  • 2. Modes and classes of modes of action of physiologically active substances of receptor type under conditions of screening.
    Dmitrieva NV; Kaplun AB; Kosolapov SS; Lobanov VI; Nizhnii SV; Piruzyan LA; Pronin VI
    Biol Bull Acad Sci USSR; 1980; 7(3):223-8. PubMed ID: 7317510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criteria for selection of physiologically active substances (pharmacometry under screening conditions).
    Dmitrieva NV; Kaplun AB; Lobanov VI; Nizhnii SV; Piruzyan LA
    Biol Bull Acad Sci USSR; 1979; 6(6):780-7. PubMed ID: 552856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Action of substances modifying adrenergic transmission on regeneration and scissiparity of the planarian Dugesia tigrina].
    Lenicque P; Tchapajeva L
    Therapie; 1969; 24(6):1043-58. PubMed ID: 4391607
    [No Abstract]   [Full Text] [Related]  

  • 5. [A molecular basis for the action of drugs. 3. Substances with multiple action].
    van den Brink FG
    Arzneimittelforschung; 1966 Nov; 16(11):1403-12. PubMed ID: 6015002
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacology and toxicology of directly and indirectly active sympathomimetics].
    Classen HG; Marquardt P; Schumacher KA; Späth M
    Med Welt; 1972 Apr; 23(15):536-42. PubMed ID: 5038521
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of substances affecting the central nervous system on drinking excitability].
    Berkhin EB; Sidorenkova NB
    Fiziol Zh SSSR Im I M Sechenova; 1967 Oct; 53(10):1186-92. PubMed ID: 5615241
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of toxic effects of cystamine by adrenergic agents in rats.
    Volenec K; Kuna P
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1981; 24(4):541-7. PubMed ID: 6978517
    [No Abstract]   [Full Text] [Related]  

  • 9. [Demonstration of participation of adrenergic regulations in variations of appetency for alcohol in rats].
    Soulairac A; van Steenkiste J; van Steenkiste JN
    J Physiol (Paris); 1970; 62 Suppl 2(2):318-9. PubMed ID: 5530139
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypothermal action of alpha sympathomimetic substances. Antagonism with some adrenolytics and cholinolytics].
    Tsoucaris-Kupfer D; Schmitt H
    C R Acad Hebd Seances Acad Sci D; 1972 Jan; 274(4):607-10. PubMed ID: 4622362
    [No Abstract]   [Full Text] [Related]  

  • 11. [Response of spontaneous rhythmic activity of isolated bovine gastric artery to the action of adrenergic drugs].
    Ciocatto E; Cassiano O; Pasquè A
    Minerva Anestesiol; 1968 Jun; 34(6):752-6. PubMed ID: 5739179
    [No Abstract]   [Full Text] [Related]  

  • 12. [Behavior of blood catecholamines under the action of sympathomimetic and sympatholytic drugs].
    Di Biase G; Labriola E
    Arch Patol Clin Med; 1965 Dec; 42(2):114-25. PubMed ID: 5860702
    [No Abstract]   [Full Text] [Related]  

  • 13. [Distribution and role of the adrenergic receptors: therapeutic value].
    Moline J; Harichaux P
    Presse Med (1893); 1967 Apr; 75(18):901-4. PubMed ID: 6023843
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interactions between adrenergics, adrenolytics and monoamine oxidase inhibitors].
    Marmo E; Sarluca F
    Clin Ter; 1966 Apr; 37(1):3-24. PubMed ID: 5919308
    [No Abstract]   [Full Text] [Related]  

  • 15. [The adrenergic receptors. Critical classification].
    Cardiol Prat; 1968 Feb; 19(1):61-71. PubMed ID: 5685529
    [No Abstract]   [Full Text] [Related]  

  • 16. Adrenergic mediators.
    Nickerson M
    Invest Ophthalmol; 1965 Dec; 4(6):1085-94. PubMed ID: 5321925
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the noradrenaline alpha-receptor. I. Techniques of receptor isolation. The distribution and specificity of action of N-(2-bromoethyl)-N-ethyl-1-naphthylmethylamine, a competitive antagonist of noradrenaline.
    Moran JF; May M; Kimelberg H; Triggle DJ
    Mol Pharmacol; 1967 Jan; 3(1):15-27. PubMed ID: 6030889
    [No Abstract]   [Full Text] [Related]  

  • 18. Adrenergic receptors and the physician.
    Somani P
    Wis Med J; 1968 Jun; 67(6):296-300. PubMed ID: 5655731
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacodynamic agents acting on the adrenergic receptors: their applications in cardiology].
    Warembourg H; Bertrand M; Delomez M
    Lille Med; 1967 Jan; 12(1):77-81. PubMed ID: 5597458
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of adrenergic stimulant and blocking drugs on cerebral electrical activity in curarized animals.
    GOLDSTEIN L; MUNOZ C
    J Pharmacol Exp Ther; 1961 Jun; 132():345-53. PubMed ID: 13706655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.